Healthcare
Live Price
Offline$0.0001
+0.00% today
Window Change
+0.00%
Window
Jun 23, 2025 → Dec 30, 2025
Historical coverage is still expanding
This 1Y daily history view is usable, but not fully loaded yet. Additional bars will appear as backfills continue.
Coverage: 133 bars · Jun 23, 2025 → Dec 30, 2025
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Tibet Pharmaceuticals, Inc. (TBET) is a Healthcare stock with a market cap of $1.49K and listed on OTC. The stock last traded around $0.00 and up 0.0% across the available one-year price window (Jun 23, 2025 → Dec 30, 2025). Baseline metrics include revenue growth of +40.7%, EPS growth of +40.5%, a dividend yield of 0.0%. What stands out right now is revenue +40.7%, EPS +40.5%, free cash flow -25.4% with operating margin 41.1% and ROIC 0.0%. Valuation is more restrained than many high-expectation growth names at P/E 0.0 and price/sales 0.0. Stock Foundry combines TBET price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
TBET
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
TBET Max Drawdown
0.00%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for TBET and SPY.
Powered by FMP stock_dividend. Includes historical ex-dates, pay dates, and payout amounts.
Dividend Yield
No active yield
Trailing 12M Payout
$0.00
Last Payout
—
Next Step
Dividend yield means more when it is matched with payout durability, earnings quality, and sector context.